123 Main Street, New York, NY 10001

Top Navigation with Mega Menu

Co-Dx™ reports massive jump in Q1 profits

Revenue boost attributed to sales of its test for SARS-CoV-2.

Co-Dx announced a massive jump in first quarter revenues due in large part to strong sales of its Logix Smart COVID-19 test for SARS-CoV-2, recording a 13-fold increase year over year. Sales of the PCR-based test surged thanks to Emergency Use Authorization from the U.S. Food and Drug Administration.

Read the article here: